{
    "clinical_study": {
        "@rank": "107594", 
        "arm_group": {
            "arm_group_label": "patient with alzheimer's disease", 
            "description": "Cohort of patients with psychological symptoms of dementia hospitalised in Cognitive and Behaviorial Units (CBUs)\nEvaluation of these units through the observation of the behavioral and psychological symptoms of dementia evolution : NPI score, caregivers quality of life, caregivers burden, collection of psychotropic drugs, the rehospitalisation rate"
        }, 
        "brief_summary": {
            "textblock": "Cognitive and behavioral units (CBUs) have been created between 2008 and 2012 French\n      National Alzheimer plan for the management of behavior problems of patients suffering from\n      Alzheimer's disease or other related disorders and necessitating hospitalisation. This\n      Alzheimer plan is promoting the evaluation of these units through the observation of the\n      behavioral and psychological symptoms of dementia (BPSD) evolution.  As these units are new,\n      it appears important to assess their long-term impact on patients care."
        }, 
        "brief_title": "Patients With Behavioural Symptoms and Hospitalized in Cognitive and Behavioural Units", 
        "completion_date": {
            "#text": "October 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Alzheimer Disease", 
        "condition_browse": {
            "mesh_term": [
                "Alzheimer Disease", 
                "Behavioral Symptoms"
            ]
        }, 
        "detailed_description": {
            "textblock": "EXPECTED RESULTS The present study should allow to better understand the long-term impact of\n      CBU on care of patients with Alzheimer disease and BPSD. Moreover, it should allow to\n      identify patients improved by CBU."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patient hospitalized on CBUs\n\n          -  patient with the diagnostic criteria for disease related to dementia stage with a\n             Clinical Demential Rating \u2265 1\n\n          -  patient with a caregiver who is fairly frequent contact with the patient in order to\n             observe the appearance of behavior changes\n\n        Exclusion Criteria:\n\n          -  Patient living alone at home\n\n          -  Patient with risk of death within one year"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients with Alzheimer's disease or associated disorders and BDSP and hospitalized in a\n        CBU"
            }
        }, 
        "enrollment": {
            "#text": "306", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01901263", 
            "org_study_id": "1208125", 
            "secondary_id": "13.069bis"
        }, 
        "intervention": {
            "arm_group_label": "patient with alzheimer's disease", 
            "description": "the Neuropsychiatric Inventory (NPI), is uded to assess 10 behavioral disturbances occurring in dementia patients: delusions, hallucinations, dysphoria, anxiety, agitation/aggression, euphoria, disinhibition, irritability/lability, apathy, and aberrant motor activity. The NPI uses a screening strategy to minimize administration time, examining and scoring only those behavioral domains with positive responses to screening questions.", 
            "intervention_name": "patients with alzheimer's disease", 
            "intervention_type": "Behavioral"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Cognitive and behavioral units", 
            "Alzheimer Disease", 
            "Dementia"
        ], 
        "lastchanged_date": "January 28, 2014", 
        "location": [
            {
                "contact": {
                    "last_name": "Florence Dibie\u2010Racoupeau, MD", 
                    "phone": "04 37 90 12 01"
                }, 
                "facility": {
                    "address": {
                        "city": "Lyon", 
                        "country": "France", 
                        "zip": "69373"
                    }, 
                    "name": "CH Saint Jean de Dieu"
                }, 
                "investigator": [
                    {
                        "last_name": "Florence Dibie\u2010Racoupeau", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "C\u00e9dric Granet", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "isabelle.rouch@chu-st-etienne.fr", 
                    "last_name": "Isabelle Rouch, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Saint Etienne", 
                        "country": "France", 
                        "zip": "42000"
                    }, 
                    "name": "CHU de Saint Etienne"
                }, 
                "investigator": [
                    {
                        "last_name": "Isabelle Rouch", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Chantal Girtanner", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "G\u00e9raldine Martin\u2010Gaujard, MD", 
                    "phone": "04 72 43 20 50"
                }, 
                "facility": {
                    "address": {
                        "city": "Villeurbanne", 
                        "country": "France", 
                        "zip": "69100"
                    }, 
                    "name": "Hospices Civils de Lyon"
                }, 
                "investigator": {
                    "last_name": "G\u00e9raldine Martin\u2010Gaujard", 
                    "role": "Sub-Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_groups": "1", 
        "official_title": "Initial and Long-term Evaluation of Patients With Behavioural Symptoms and Hospitalized in Cognitive and Behavioural Units", 
        "overall_contact": {
            "email": "isabelle.rouch@chu-st-etienne.fr", 
            "last_name": "Isabelle ROUCH, PhD", 
            "phone": "(0)477127398", 
            "phone_ext": "+33"
        }, 
        "overall_official": {
            "affiliation": "CHU de Saint-Etienne", 
            "last_name": "Isabelle ROUCH, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: French Data Protection Authority", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "impact of CBU effectiveness in reducing BPSD", 
            "measure": "Neuropsychiatric Inventory (NPI) score", 
            "safety_issue": "No", 
            "time_frame": "one year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01901263"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "CBU effectiveness in reducing BPSD", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "measure": "CBU effectiveness on quality of life of patients and caregivers, and on caregivers' burden", 
                "safety_issue": "No", 
                "time_frame": "one year"
            }, 
            {
                "measure": "Psychotropic drugs (in particular neuroleptic drugs) consumption", 
                "safety_issue": "No", 
                "time_frame": "one year"
            }, 
            {
                "measure": "rehospitalisation rate for BPSD of the patients in the year following their hospitalisation in CBU", 
                "safety_issue": "No", 
                "time_frame": "one year"
            }
        ], 
        "source": "Centre Hospitalier Universitaire de Saint Etienne", 
        "sponsors": {
            "collaborator": {
                "agency": "Agence R\u00e9gionale de la Sant\u00e9 - Rh\u00f4ne Alpes", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Centre Hospitalier Universitaire de Saint Etienne", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "3 Years", 
        "verification_date": "January 2014"
    }
}